Net Income for Boston Scientific (BSX)
According to Boston Scientific's latest reported financial statements, the company's current net income (TTM) is $3.55B USD. Net income is the bottom-line profit after all expenses — cost of goods sold, operating expenses, interest, and taxes — are subtracted from revenue. It is the figure used to compute earnings per share (EPS) and is the residual available to shareholders.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingNet IncomeSwitch metric
TTM (last 4 quarters)
$3.55B
YoY change
+55.7%
5Y CAGR
N/A
Peak year (2019)
$4.70B
Cumulative net income
$6.03B
Net Income history chart for Boston Scientific (BSX) from 1991 to 2025
Net Income history table for Boston Scientific (BSX) from 1991 to 2025
| Fiscal year | Period ended | Reported | Net Income | YoY |
|---|---|---|---|---|
| 2025 | $2.89B | +55.7% | ||
| 2024 | $1.85B | +16.4% | ||
| 2023 | $1.59B | +128.2% | ||
| 2022 | $698.00M | -32.9% | ||
| 2021 | $1.04B | -1368.3% | ||
| 2020 | -$82.00M | -101.7% | ||
| 2019 | $4.70B | +181.3% | ||
| 2018 | $1.67B | +1506.7% | ||
| 2017 | $104.00M | -70.0% | ||
| 2016 | $347.00M | -245.2% | ||
| 2015 | -$239.00M | +100.8% | ||
| 2014 | -$119.00M | -1.7% | ||
| 2013 | -$121.00M | -97.0% | ||
| 2012 | -$4.07B | -1022.4% | ||
| 2011 | $441.00M | -141.4% | ||
| 2010 | -$1.06B | +3.9% | ||
| 2009 | -$1.02B | -49.7% | ||
| 2008 | -$2.04B | +311.3% | ||
| 2007 | -$495.00M | -86.2% | ||
| 2006 | -$3.58B | -669.6% | ||
| 2005 | $628.00M | -40.9% | ||
| 2004 | $1.06B | +125.0% | ||
| 2003 | $472.00M | +26.5% | ||
| 2002 | $373.00M | -790.7% | ||
| 2001 | -$54.00M | -114.5% | ||
| 2000 | $373.00M | +0.5% | ||
| 1999 | $371.00M | -240.3% | ||
| 1998 | -$264.40M | -289.8% | ||
| 1997 | $139.30M | -16.6% | ||
| 1996 | $167.10M | +1988.8% | ||
| 1995 | $8.00M | -90.0% | ||
| 1994 | $79.70M | +14.3% | ||
| 1993 | $69.70M | +23.1% | ||
| 1992 | $56.60M | +35.4% | ||
| 1991 | $41.80M | — |
Net Income values are taken from Boston Scientific's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of Boston Scientific (BSX) net income is $2.89B – surged 55.7% year-over-year.
Boston Scientific net income plunged from $4.70B in 2019 to $2.89B in 2025, a 38.6% drawdown.
$4.70B stands as the all-time-high annual net income, posted in 2019, against a low of -$4.07B during 2012.
Among 8 Healthcare peers, Boston Scientific (BSX) ranks 9th; the peer median for net income is $15.15B.
Boston Scientific Net Income by Year
Boston Scientific Net Income 2025: $2.89B
Boston Scientific net income in 2025 was $2.89B, surged 55.7% from 2024.
Boston Scientific Net Income 2024: $1.85B
Boston Scientific net income in 2024 was $1.85B, grew 16.4% from 2023.
Boston Scientific Net Income 2023: $1.59B
Boston Scientific net income in 2023 was $1.59B, surged 128.2% from 2022.
Boston Scientific Net Income 2022: $698.00M
Boston Scientific net income in 2022 was $698.00M, plunged 32.9% below 2021.
Boston Scientific Net Income 2021: $1.04B
Boston Scientific net income in 2021 was $1.04B.
See more financial history for Boston Scientific (BSX).
Sector peers — Net Income
Companies in the same sector as Boston Scientific, ranked by their latest net income.
| Company | Net Income | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $102.43B | Healthcare |
| Johnson & Johnson (JNJ) | $26.80B | Healthcare |
| Eli Lilly and Company (LLY) | $20.64B | Healthcare |
| Merck & Co., Inc. (MRK) | $18.25B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $12.06B | Healthcare |
| AstraZeneca PLC (AZN) | $10.26B | Healthcare |
| Amgen Inc. (AMGN) | $7.71B | Healthcare |
| AbbVie Inc. (ABBV) | $4.23B | Healthcare |
Frequently asked questions
What is Boston Scientific's net income?
- Latest reported net income for Boston Scientific (BSX) is $3.55B (period ending March 31, 2026).
How has Boston Scientific net income changed year-over-year?
- Boston Scientific (BSX) net income changed +55.7% year-over-year on the latest annual filing.
When did Boston Scientific net income hit its highest annual value?
- Boston Scientific net income reached its highest annual value of $4.70B in 2019.
What was Boston Scientific net income in 2024?
- Boston Scientific (BSX) net income in 2024 was $1.85B.
What was Boston Scientific net income in 2025?
- Boston Scientific (BSX) net income in 2025 was $2.89B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
BSX Overview
Company profile, financial tools, and key metrics
BSX Revenue Counter
Earns $653.70 every second. See per minute, hour, and day.
BSX Earnings Counter
Earns $112.66 per second net profit. See per minute, hour, and day.
BSX Economic Scale
Exceeds Niger's GDP. Compare with world economies.
BSX What If Invested
What if you had invested $1,000? See historical returns from any date.
BSX How It Makes Money
Discover visual breakdown of $20.61B in revenue — where it comes from and where it goes.
BSX Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
BSX Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
BSX Daily Price Character
Balanced · 48.8% historical win rate (green days). Streaks & record days.
BSX Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
BSX Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.